FDA Urged to Reject Dangerous Over-The-Counter Abortion Drug

FDA Urged to Reject Dangerous Over-The-Counter Abortion Drug      Today, Americans United for Life filed testimony with the Food & Drug Administration (FDA) Advisory Committee for Reproductive Health Drugs, urging the FDA not to approve the abortion drug Ulipristal or make it available over-the-counter. "The FDA and abortion proponents are misrepresenting Ulipristal as an 'emergency contraception' drug -- it's simply the next generation of RU-486," said Dr. Charmaine Yoest, President and CEO of Americans United for Life. "The American people need to know that Ulipristal is a dangerous drug that will place women's lives in danger." The abortion drug RU-486 is the parent compound of Ulipristal. RU-486 subjects women to drastic health risks, including risks of bacterial infection and hemorrhage. To date, at least 13 women have died after using RU-486. Ulipristal is subject to similar risks, and unsupervised, over-the-counter access would put countless women's lives in danger. Click here to read the  testimony filed by Americans United for Life with the FDA Advisory Committee. Contact: Matthew Faraci Source: Americans United for Life Publish Date: June 1, 2010 Link to this article. Send this article to a friend.